Trade MIRA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
MIRA Pharmaceuticals, Inc. (MIRA) is trading at US$0.77, down 1.95% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$32.09M. Over the past 52 weeks, MIRA has traded between US$0.60 and US$2.45. On Syfe you can trade MIRA with $0 commission and add it to your watchlist.
| Previous close | US$0.79 |
|---|---|
| Market cap | US$32.09M |
| 52-week range | US$0.60 – US$2.45 |
| Volume | 105.53K |
| Exchange | US |
Add to Watchlist
Set Price Alert
MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. It engages in developing its product candidates, Ketamir-2 and MIRA-55, designed to address unmet medical needs in pain management, depression, PTSD, and cognitive function. The company was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.
Year: 2023
Mira Pharmaceuticals Oral Form Shows 'Positive' Results in Pre-Clinical Studies
Jul 10, 12:33 PM · MT Newswires
Mira Pharmaceuticals Says SKNY-1 in Obesity, Addiction Shows 'Favorable' Bioavailability in Preclinical Studies
Jul 6, 1:44 PM · MT Newswires
Mira Pharmaceuticals Submits Phase 2a Trial Protocol for Ketamir-2 to FDA
Jun 17, 12:30 PM · MT Newswires
Mira Pharmaceuticals Secures Worldwide Rights to MIRA-55, SKNY-1 Drug Candidates
Jun 4, 12:32 PM · MT Newswires
MIRA Pharmaceuticals, Inc. (MIRA) stock is trading at US$0.77, -1.95% from the previous close of US$0.79.
The market cap for MIRA Pharmaceuticals, Inc. (MIRA) stock is approximately US$32.09M.
The 52-week high for MIRA Pharmaceuticals, Inc. (MIRA) stock is US$2.45.
The 52-week low for MIRA Pharmaceuticals, Inc. (MIRA) stock is US$0.60.
MIRA Pharmaceuticals, Inc. (MIRA) does not currently pay a dividend.
Stay on top of MIRA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
